Sung Joon Kim

Sung Joon Kim

Auto-generated profile, based on publicly available information

Sung Joon Kim

Department of Chemistry, Howard University, Washington, District of Columbia 20059, United States

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
SKSung Joon Kim
Sung Joon Kim
JCJames Chang
James Chang
MSManmilan Singh
Manmilan Singh

1 March 2008 in Journal of Molecular Biology
Verified
Journal Article
Closed access
SKSung Joon Kim
Sung Joon Kim
LCLynette Cegelski
Lynette Cegelski
DSDirk Stueber
Dirk Stueber
MSManmilan Singh
Manmilan Singh
EDEvelyne Dietrich
Evelyne Dietrich
JSJacob Schaefer
Jacob Schaefer

4 January 2018 in ACS Omega
Verified
Journal Article
Open access
FWFeng Wang
Feng Wang
HZHongyu Zhou
Hongyu Zhou
OOOlatunde P. Olademehin
Olatunde P. Olademehin
SKSung Joon Kim
Sung Joon Kim
PTPeng Tao
Peng Tao
Vancomycin is a glycopeptide antibiotic used for the treatment of serious infections by Gram-positive pathogens. Vancomycin inhibits cell wall biosynthesis by targeting the d-Ala-d-Ala terminus of peptidoglycan (PG). The highly cross-linked heptapeptide aglycon structure of vancomycin is the d-Ala-d-Ala binding site. The first residue of vancomycin is N-methyl-leucine, which is crucial for the dipeptide binding. The removal of N-methyl-leucine by Edman degradation results in desleucyl-vancomycin devoid of antimicrobial activities. To investigate the function of N-methyl-leucine for the dipeptide binding in vancomycin, molecular dynamics simulations of vancomycin and three N-terminus-modified vancomycin derivatives: desleucyl-vancomycin, vancomycinNtoC, and vancomycinSar, binding to a PG unit of the sequence l-Ala-d-iso-Gln-l-Lys-d-Ala-d-Ala with an intact pentaglycine bridge structure attached to the bridge link of l-Lys were carried out. Glycopeptide–PG binding interactions were characterized by root-mean-square-deviation contour analysis of atomic positions in vancomycin and its three analogues bound to a PG unit. The overall sampling space for four glycopeptide–PG complexes shows four distinct distributions with a continuous change between the conformational spaces. The hydrogen bond analyses show that multiple hydrogen bonds between the d-Ala-d-Ala and the vancomycin aglycon structure strengthened the dipeptide binding. The simulations revealed that the removal or chemical modification of N-methyl-leucine significantly weakens the dipeptide binding to the aglycon structure and provides interesting structural insights into glycopeptide–PG binding interactions.


5 September 2019 in ACS Chemical Biology
Verified
Journal Article
Open access
SPSean E. Pidgeon
Sean E. Pidgeon
AAAlexis J. Apostolos
Alexis J. Apostolos
JNJulia M. Nelson
Julia M. Nelson
MSMoagi Shaku
Moagi Shaku
BRBinayak Rimal
Binayak Rimal
MPMarcos M. Pires
Marcos M. Pires
Peptidoglycan (PG) is a crosslinked, mesh-like scaffold endowed with the strength to withstand the internal pressure of bacteria. Crosslinking of peptide chains within PG is an essential process and its disruption thereof underpins the potency of several classes of antibiotics. Two primary crosslinking modes have been identified that are carried out by D,D-transpeptidases and L,D-transpeptidases (Ldts). The nascent PG from each enzymatic class is structurally unique, which results in different crosslinking configurations. Recent advances in PG cellular probes have been powerful in advancing the understanding of D,D-transpeptidation by Penicillin Binding Proteins (PBPs). In contrast, no cellular probes have been previously described to directly interrogate Ldt function in live cells. Herein, we describe a new class of Ldt-specific probes composed of structural analogs of nascent PG, which are metabolically incorporated into the PG scaffold by Ldts. With a panel of tetra-peptide PG stem mimics, we demonstrated that subtle modifications such as amidation of iso-Glu can control PG crosslinking. Ldt-probes were applied to quantify and track the localization of Ldt activity in Enterococcus faecium, Mycobacterium smegmatis, and Mycobacterium tuberculosis. These results confirm that our Ldt probes are specific and suggest that the primary sequence of the stem peptide can control Ldt crosslinking levels. We anticipate that unraveling the interplay between Ldts and other crosslinking modalities may reveal the organization of the PG structure in relation to the spatial localization of crosslinking machineries.

1 October 2009 in Journal of Molecular Biology
Verified
Journal Article
Closed access
GPGary J. Patti
Gary J. Patti
SKSung Joon Kim
Sung Joon Kim
TYTsyr-Yan Yu
Tsyr-Yan Yu
EDEvelyne Dietrich
Evelyne Dietrich
KTKelly S.E. Tanaka
Kelly S.E. Tanaka
JSJacob Schaefer
Jacob Schaefer